Search research articles
Contact Us
Filters
Showing results (181-190 of 276) with videos related to
Page
of 28
Sort By:
Frontiers in Immunology
|
November 3, 2022
<i>HLA-C</i> dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
Eleonora Loi, Loredana Moi, Paola Cabras, et al.
Diabetes Care
|
January 30, 2004
Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? The Diabetes Autoimmunity Study in the Young (DAISY)
Heather M Stanley, Jill M Norris, Katherine Barriga, et al.
Nature Genetics
|
April 1, 1993
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families
H A Erlich, A Zeidler, J Chang, et al.
International Journal of Cancer
|
August 11, 2007
Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer
Emma L Ivansson, Inger M Gustavsson, Jessica J Magnusson, et al.
Science (New York, N.Y.)
|
January 29, 1988
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
R K Saiki, D H Gelfand, S Stoffel, et al.
The Journal of Clinical Investigation
|
March 1, 1989
A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles
M J Sheehy, S J Scharf, J R Rowe, et al.
Tissue Antigens
|
November 26, 2002
The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos
T L Bugawan, W Klitz, M Alejandrino, et al.
The Journal of Clinical Investigation
|
October 28, 1998
Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family
C F Verge, P Vardi, S Babu, et al.
Diabetes, Obesity & Metabolism
|
January 16, 2009
The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes
E E Baschal, T A Aly, J M Jasinski, et al.
Genes and Immunity
|
December 4, 2009
Association analysis of SNPs in the IL4R locus with type I diabetes
H A Erlich, K Lohman, S J Mack, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 276) with videos related to
Sort By:
Page
of 28
Frontiers in Immunology
|
November 3, 2022
<i>HLA-C</i> dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
Eleonora Loi, Loredana Moi, Paola Cabras, et al.
Diabetes Care
|
January 30, 2004
Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? The Diabetes Autoimmunity Study in the Young (DAISY)
Heather M Stanley, Jill M Norris, Katherine Barriga, et al.
Nature Genetics
|
April 1, 1993
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families
H A Erlich, A Zeidler, J Chang, et al.
International Journal of Cancer
|
August 11, 2007
Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer
Emma L Ivansson, Inger M Gustavsson, Jessica J Magnusson, et al.
Science (New York, N.Y.)
|
January 29, 1988
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
R K Saiki, D H Gelfand, S Stoffel, et al.
The Journal of Clinical Investigation
|
March 1, 1989
A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles
M J Sheehy, S J Scharf, J R Rowe, et al.
Tissue Antigens
|
November 26, 2002
The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos
T L Bugawan, W Klitz, M Alejandrino, et al.
The Journal of Clinical Investigation
|
October 28, 1998
Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family
C F Verge, P Vardi, S Babu, et al.
Diabetes, Obesity & Metabolism
|
January 16, 2009
The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes
E E Baschal, T A Aly, J M Jasinski, et al.
Genes and Immunity
|
December 4, 2009
Association analysis of SNPs in the IL4R locus with type I diabetes
H A Erlich, K Lohman, S J Mack, et al.
Page
of 28